Clozapine and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Clozapine, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Clozapine and have Ataxia aggravated. It is created by eHealthMe based on reports of 66,100 people who have side effects when taking Clozapine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
66,100 people reported to have side effects when taking Clozapine.
Among them, 119 people (0.18%) have Ataxia aggravated.
What is Clozapine?
Clozapine has active ingredients of clozapine. It is often used in schizophrenia. eHealthMe is studying from 66,415 Clozapine users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 915 drugs and 340 conditions by eHealthMe.
Number of Clozapine and Ataxia aggravated reports submitted per year:
Time on Clozapine when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Clozapine*:
Age of people who have Ataxia aggravated when taking Clozapine *:
Common drugs people take besides Clozapine *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Clozapine and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Grover S, Sahoo S, "Clozapine induced akathisia: A case report and review of the evidence", Indian journal of pharmacology, 2015 Jan .
- Yaylaci S, Yilmaz EU, Guclu E, Kumsar NA, Tamer A, Karabay O, "Clozapine-Induced Febrile Neutropenia and Cellulitis", Turkish journal of emergency medicine, 2014 Mar .
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of clozapine:
Alternative drugs to, pros and cons of Clozapine:
- Clozapine (66,415 reports)
Common Clozapine side effects:
Browse all side effects of Clozapine:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (915 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (340 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on clozapine (the active ingredients of Clozapine) and Clozapine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Paxil and Skin Irritation - now
- Hepatitis Toxic and drugs of ingredients of amino acids - 12 seconds ago
- Nausea And Vomiting and Creatinine Renal Clearance Decreased - 13 seconds ago
- Differential White Blood Cell Count Abnormal and drugs of ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate - 16 seconds ago
- Nasonex and Activities Of Daily Living Impaired - 19 seconds ago
- Azithromycin and Hepatic Vein Thrombosis - 23 seconds ago
- Ibu and Rectal Tenesmus - 24 seconds ago
- Pexeva and Withdrawal Syndrome - 24 seconds ago
- Clopidogrel Bisulfate and Actinomycosis - 28 seconds ago
- Brilinta and Breast Lump - 37 seconds ago